| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8344030 | Molecular Genetics and Metabolism | 2012 | 5 Pages |
Abstract
⺠Bezafibrate decreased acylcarnitines in several FAO disorders in vitro. ⺠Bezafibrate improved abnormalities in a child with glutaric acidemia type 2. ⺠Bezafibrate is a promising treatment option for FAO disorders. ⺠In vitro probe assay can evaluate the effect of drugs to treat FAO disorders.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Seiji Yamaguchi, Hong Li, Jamiyan Purevsuren, Kenji Yamada, Midori Furui, Tomoo Takahashi, Yuichi Mushimoto, Hironori Kobayashi, Yuki Hasegawa, Takeshi Taketani, Toshiyuki Fukao, Seiji Fukuda,